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Abstract 
The article is a minireview on the use of biomaterials in medicine. Biomaterials have a central role in 
biomedical industry, being required in a broad range of medical applications for the purpose of diagnosis, prevention 
and therapy. They are used in orthopedics, vascular therapy, trauma, esthetic surgery, ophthalmology, maxillo-facial 
surgery, cardiology, urology and neurology by being integrated in implants, devices, prosthesis and drug-delivery 
systems. The metallic alloys are considered dominant biomaterials The main metalic representatives are commercially 
pure titanium, titanium alloys (Ti-6AI-4V, Ti-6Al7Nb, Ti-5Al-2.5Fe), stainless steel (316 and 316 L), tantalum, Co-Cr- 
Mo alloys and Mg alloys. Bioceramics became a group of materials of great importance for maxillo-facial surgery and 
orthopedics. Polymeric materials have a growing medical importance. Due to their biocompatibility, similar resistance 
of cortical bone, good corrosion resistance in the physiological environment. 
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Introduction 
Biomaterials have a central role in biomedical industry, being required in a broad range 
of medical applications for the purpose of diagnosis, prevention and therapy. They have found 
application in orthopedics, vascular therapy, trauma, esthetic surgery, ophthalmology, maxillo- 
facial surgery, cardiology, urology and neurology by being integrated in implants, devices, 
prosthesis and drug-delivery systems. 
Biomaterial science combines physics, chemistry, medicine and materials science with 
the main purpose of continuous development and translation of biomaterials to clinical use. As a 
result of ongoing research, there is currently a wide variety of biomaterial alternatives with medical 
applicability available on the market. Biomaterials may be natural or synthetic. They can be 
metallic materials ornon-metallic materialssuch as polymeric compounds, composite materialsor 
ceramic materials. 
From a practical and medical point of view, the metallic materials are considered 
dominant biomaterials, but nowadays there is a significant growth of other new biomaterials who 
are gaining increasing attention in the medical field. 
The main metallic representatives are commercially pure titanium, titanium alloys (Ti- 
6AI-4V, Ti-6Al7Nb, Ti-5Al-2.5Fe), stainless steel (316 and 316 L), tantalum, Co-Cr-Mo alloys 
and Mg alloys. Those have a wide use in surgery lines due to their inert behavior, good 
biocompatibility and osteointegration capacity, good mechanical properties and compatibility with 
MRI scanning and other medical imaging techniques by having non-magnetic properties, excellent 
corrosion resistance in the physiological environment given by the stability of the oxide layer 
formed on the surface of the implant material when it comes about Ti(21), Tantalum and Co-Cr-Mo 
alloys (1,2), which helps with the passivation of the implant, or biodegradation kinetic in case of of 
Mg alloys (4,5,16,17,19,24,25). 
Porous tantalum implants are relatively new in orthopedics but along with the advantages 
from above, its high porosity and its functional and mechanical properties similar to bone tissue 
made porous tantalum a highly attractive biomaterial (6,7,8,15,26,27). 
Bioceramics became a group of materials of great importance for maxillo-facial surgery 
and orthopedics, with three basic classes: inert ceramics (alumina, zirconia, carbon), bioactive 






Inert ceramics are highly attractive as dental implants due to their good stability and 
esthetics, biocompatibility with paradontal tissues and compatibility with medical imaging 
techniques, minimal thermal and electrical conductivity and chemical inertness and they can be the 
first choice in patients with titanium allergy. 
Bioglass and glass ceramics show good biocomptibility, lack of cytotoxic effects, 
superior mechanical properties and the ability of forming an active layer of hydroxiapatite at the 
bone-implant interface that stimulates osteogenesis(9,18), attributes that helped them find a place in 
dental and orthopedic surgery lines. 
Biodegradable ceramics such as hydroxyapatite which is the essential mineral component 
of the bone tissue, are ceramic materials based on calcium phosphate with a porous structure and 
high degree of similarity with the bone, characteristics that gives them a special bone-bonding 
ability. This bone-binding ability manifests by releasing calcium and phosphate ions followed by 
absorption by adjacent bone tissue, interactions that stimulate positive biological reactions at the 
material-tissue interface such as bone ingrowth into the porous structure. The porosity can be 
tailored to accelerate the physical dissolution process and the biological process of cell attachment 
and osteoid deposition(10). 
Polymeric materials have a growing medical importance. Due to their biocompatibility, 
similar resistance of cortical bone, good corrosion resistance in the physiological environment(11,12, 
22,23) and their versatility, they are creating excitement in the biomaterials field. They can be tailored 
to have specific mechanical and physical properties in order to comply with the implant 
applications. Three of the most representative polymeric materials are PEEK 
(polyetheretherketone), PLA (polylactic acid) and PGA (polyglycolic acid). They can be used as 
alternatives to titanium implants in orthopedics, cranioplasty, osteotomy, maxillo-facial 
reconstructions and spinal surgery. 
Biomaterials are being widely used in medicine from a long period of time in the form 
of devices, drug delivery systems or implants (stents, ligaments, prosthesis, screws,vascular grafts, 
heart valves, rods, plates, etc.) to repair damaged tissue, help with tissue regeneration or to restore 
tissue function. Appropriate selection of biomaterials plays a key role in biological response and 
to clinical performance. A biomaterial must possess multiple properties in order to be eligible, such 
as: biocompatibility (”the ability of a material to perform with an appropriate host response in a 
specific application"(12)), biostability (chemical, biological and structural resistance), 
biofunctionality(13), high corrosion resistance, no cytotoxic effects, good mechanical properties and 
to respect functional tissue structure and pathobiology when used as implants. 
Therefore, all biomaterial science efforts are and will be focused on continually 
improving biomaterials, tissue-implant interface through bulk and surface modification (physical 
and chemical approaches, design of a bioactive surface implant), in order to enhance their medical 
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